Sort
51,593 grants matching “hepatitis”
Testing an mHealth System for Integrating Alcohol Use Treatment with Hepatology Care for Patients with Alcohol-associated Liver Disease
$630,575Andrew Quanbeck · University Of Wisconsin-Madison · R01 · FY2023 · AA
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$630,556Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Development of simpler immunotheraputics
$630,497Arya Biragyn · National Institute On Aging · ZIA · FY2021 · AG
Pathogenesis of HIV and HCV in Hemophilia: HGDS
$630,488Children'S Hospital Los Angeles · R01 · FY2003 · HD
Social Media Mining for Pharmacovigilance
$630,471Graciela Gonzalez Hernandez · University Of Pennsylvania · R01 · FY2019 · LM
Biological Mechanisms through which TMAO Promotes Atherosclerosis
$630,470Hooman Allayee · University Of Southern California · R01 · FY2020 · HL
Multidisciplinary Studies of Hematopoietic Malignancies
$630,447Lindsay Morton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Creation of in vivo active chemical probes for CAMKK2 to treat cancer
$630,383David Harold Drewry · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Bio-digital Rapid Alert to Identify Neuromorbidity
$630,376Robert S. Clark · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · NS
Community-based interventions to reduce mortality from neonatal infection
$630,365Waldemar A. Carlo · University Of Alabama At Birmingham · U01 · FY2012 · HD
IDENTIFICATION AND PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC APPROACHES TO DYSKERATOSIS CONGENITA
$630,241Frederick Bradley Johnson · University Of Pennsylvania · R01 · FY2021 · HL
Development of Natural Product Leads as Anticancer Therapeutics
$630,232John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
CSDE1 as a Post Transcriptional Regulator of the LDLR
$630,223John S Chorba · University Of California, San Francisco · R01 · FY2023 · HL
Search For New and Emerging Etiologic Agents
$630,214Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Drug target validation of the enterovirus D68 2A protease
$630,155Jun Wang · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
Developmental pathways, environmental agents, and epigenetics in liver disease
$630,122Keith D Robertson · Augusta University · R01 · FY2011 · AA
Approach for in vivo gene delivery into hematopoietic stem cells for hemophilia A therapy
$630,041Andre Michael Lieber · University Of Washington · R01 · FY2019 · HL
Injection Risk Networks in Rural Puerto Rico
$630,001Kirk Dombrowski · University Of Nebraska Lincoln · R01 · FY2015 · DA
IMPROVED BARRIER HOUSING FOR BIOMEDICAL RESEARCH BLDG
$630,000University Of Pennsylvania · G20 · FY2004 · RR
TESTING THE SAFETY AND EFFICACY OF CARG-201, AN RNA REPLICON-BASED THERAPEUTIC VACCINE FOR THE TREATMENT OF CHRONIC HEPATITIS B VIRUS
$629,992Carogen Corp · · FY2024 · Defense Health Agency
Estrogen Regulation of Hepatic Growth
$629,907Wolfram Goessling · Brigham And Women'S Hospital · R01 · FY2018 · DK
Estrogen Regulation of Hepatic Growth
$629,907Wolfram Goessling · Brigham And Women'S Hospital · R01 · FY2020 · DK
Estrogen Regulation of Hepatic Growth
$629,907Wolfram Goessling · Brigham And Women'S Hospital · R01 · FY2019 · DK
Estrogen Regulation of Hepatic Growth
$629,907Wolfram Goessling · Brigham And Women'S Hospital · R01 · FY2017 · DK
Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver
$629,891Qing Miao · Nyu Long Island School Of Medicine · R01 · FY2023 · DK